Trademark: 79317018
Word
NEORNAT
Status Date
Tuesday, November 15, 2022
Registration Number
6897544
Registration Date
Tuesday, November 15, 2022
Filing Date
Thursday, June 24, 2021
Published for Opposition
Tuesday, August 30, 2022
5 Anti-cancer preparations; pharmaceutical preparations for treating malignant tumours; pharmaceutical preparations and compositions for the treatment and prevention of cancer; pharmaceutical preparations and substances for the prevention of cancer; biopharmaceuticals for the treatment of cancer; pharmaceutical preparations for the treatment of cancer; diagnostic agents for pharmaceutical use; drug delivery agents in the form of in the form of tablets that facilitate the delivery of pharmaceutical preparations; pharmaceutical drugs, namely, pharmaceutical preparations for the treatment of cancer; medicines for human purposes for the treatment of cancer; pharmaceutical preparations for suppressing tumors; pharmaceutical preparations for use in oncology; pharmaceuticals for the treatment of cancer; non-prescription medicines for the treatment of cancer; biological preparations for the treatment of cancer
42 Scientific research for medical purposes in the field of cancerous diseases; scientific research for medical purposes in the area of cancerous diseases; consultancy relating to research in the field of pharmacogenetics; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; consulting services in the field of pharmaceutical research and development; pharmaceutical research and development; pharmaceutical research services; medical laboratory services; medical research laboratory services
The mark consists of the wording "NEORNAT" in indigo stylized font with the letter "E" formed by three horizontal indigo lines.
The color indigo is claimed as a feature of the mark.
Mar 29, 2023
Final Decision Transaction Processed By Ib
Mar 8, 2023
Final Disposition Notice Sent To Ib
Mar 8, 2023
Final Disposition Processed
Feb 15, 2023
Final Disposition Notice Created, To Be Sent To Ib
Nov 15, 2022
Notice Of Registration Confirmation Emailed
Nov 15, 2022
Registered-Principal Register
Aug 30, 2022
Official Gazette Publication Confirmation E-Mailed
Aug 30, 2022
Published For Opposition
Aug 10, 2022
Notification Of Notice Of Publication E-Mailed
Jul 27, 2022
Approved For Pub - Principal Register
Jul 27, 2022
Examiner's Amendment Entered
Jul 27, 2022
Notification Of Examiners Amendment E-Mailed
Jul 27, 2022
Examiners Amendment E-Mailed
Jul 27, 2022
Examiners Amendment -Written
Jul 22, 2022
Teas/Email Correspondence Entered
Jul 22, 2022
Correspondence Received In Law Office
Jul 22, 2022
Teas Response To Office Action Received
Jul 20, 2022
Applicant/Correspondence Changes (Non-Responsive) Entered
Jul 20, 2022
Teas Change Of Correspondence Received
Jul 20, 2022
Teas Change Of Domestic Representatives Address
Jul 20, 2022
Attorney/Dom.Rep.Revoked And/Or Appointed
Jul 20, 2022
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Jul 20, 2022
Teas Change Of Owner Address Received
May 24, 2022
Refusal Processed By Ib
May 16, 2022
Attorney Review Completed
May 16, 2022
Correction From Ib Entered - Attorney Review Required
May 4, 2022
Non-Final Action Mailed - Refusal Sent To Ib
May 4, 2022
Refusal Processed By Mpu
Apr 9, 2022
Correction Transaction Received From Ib
Mar 23, 2022
Non-Final Action (Ib Refusal) Prepared For Review
Mar 22, 2022
Non-Final Action Written
Mar 16, 2022
Assigned To Examiner
Aug 10, 2021
Application Filing Receipt Mailed
Aug 6, 2021
New Application Office Supplied Data Entered
Aug 5, 2021
Sn Assigned For Sect 66a Appl From Ib
Trademark Alertz updated from USPTO on 2030-01-24
